Rheumatism drug teriflunomide shows subtype-dependent effects in breast cancer cells
A cell study finds teriflunomide suppresses growth signalling in luminal breast cancer cells while triple-negative cells show adaptive kinase rewiring.
Tag: phospho-kinase
POPULAR NEWS
-
Arsenic and cadmium raise concern in Bangladesh farm soils and crops
-
Neonatal researcher Kata Kovacs links early phosphate levels to mortality risk in newborn encephalopathy
-
Rheumatism drug teriflunomide shows subtype-dependent effects in breast cancer cells
-
Patients and Doctors Rank Rare Cancer Care Needs Differently in EORTC Survey